We found that 89% T2D sera and 71% of T2D+g sera detected linear FL-BP180 in immunoblotting, while 46% of control sera contained anti-BP180 autoantibodies (Table 2). This evidence concerns the gene COL17A1 and type 2 diabetes mellitus.